Among patients with stable coronary artery disease, colchicine lowered total plaque volume compared with placebo but had no ...

Wasko, M.D.; Sue Skledar, M.P.H., B.S.Pharm. Experience with i.v. and oral colchicine at the University of Pittsburgh Medical Center (UPMC) has shown that adverse events may be moderate to severe ...